Patients with chronic renal failure (CRF) experience a significant decrease in quality of life, due both to the limitations imposed by the disease as well as the demands of the treatment that they receive. Some side effects of both illness and treatment contribute to increase the morbidity of these patients. Among them, erectile dysfunction (ED) is notable. One hundred and nineteen patients received clinical and laboratory evaluation. The following clinical data were observed: age, education, income, race, period of dialysis, period of complaints of ED, etiology of ED, use of erythropoietin, presence of arterial hypertension and=or diabetes mellitus, use of antihypertensive drugs, use of cigarettes, and psycho-emotional state of the patients. Assessment of complaints of ED was achieved using the International Index of Erectile Function (IIEF). The following laboratory data were analyzed: hemoglobin, hematocrit, free testosterone, gonadotrophin levels (FSH and LH), HDL-cholesterol, total cholesterol, prolactin, and parathyroid hormone. Statistical analysis of the means of continuous variables was performed through use of the Student's t-test. Analysis of significance of category variables was performed using the w 2 test. Descriptive analysis was obtained through use of the clinical and socio-demographic data. A multivariate model was created and the odds ratio calculated. The average age of the patients was 47.3 AE 15.9 y. The mean duration of erectile dysfunction complaints was 4 y. The average duration of dialysis was 66.2 AE 58.9 months. Prevalence of erectile dysfunction in this population was 57.9%. The main known etiology of chronic renal failure was glomerulonephritis. The main variables associated with erectile dysfunction were age, psycho-emotional state, and levels of HDL-cholesterol. This study showed a high prevalence of erectile dysfunction in the group of patients examined. Factors such as age, anxiety and depressive complaints, and dyslipidemy seem to play an important role in the origin of erectile dysfunction in such patients.
Introduction
Patients with chronic renal failure (CRF) in hemodialysis show a notable deterioration in quality of life, due both to the disease and the symptoms it produces, as well as the demands of the treatment, which keeps the patient hooked up to a machine for 3 -4 h, 3 days a week. The presence of erectile dysfunction (ED) in this group of patients contributes overwhelmingly to the decline of quality of life. The association between CRF and ED has been reported since 1975. Initial studies have demonstrated a prevalence of 50% of ED in patients with CRF. 1 Etiology in patients with CRF is multifactorial, and among the most probable causes are autonomous neuropathy, diminished concentration of testosterone, hyperprolactinemia, vascular disease of the penile arteries and veins, medication use, and psychogenic factors. 2 
Patients and methods
During the period from July to December 1999, 119 patients with CRF in hemodialysis programs were interviewed. The patients were questioned at the time of treatment in hemodialysis clinics in the city of Fortaleza, Ceará, Brazil (Pronefron, Prontorim, Prorim, Hemoce).
The sample consisted of male patients with CRF in hemodialysis programs, with a minimum age of 18 , who had agreed to take part in the study and had signed a declaration of informed consent.
During the interview, the following variables were obtained: age, skin color, level of schooling, personal and family monthly income. Educational level was further divided as follows: illiterate or literate (without formal schooling), primarylevel education, secondary-level education and college education. Patients were divided into three income brackets: up to three times the minimum wage, between three and five times the minimum wage, and greater than five times the minimum wage. (Minimum wage is approximately US$ 77 per month.)
Clinical variables included the following:
Etiology of CRF: Data obtained was based on the medical histories. When there was no report as to the cause of CRF, it was considered as being of unknown etiology. Duration of hemodialysis, in months.
Onset of complaints of ED. Duration of complaints of ED.
Smoking: Patients were considered addicted if they smoked more than 10 cigarettes a day, for at least one year. Arterial hypertension: Any patient using medication for high blood pressure, at the time of the study, was considered to have hypertension. Antihypertensive drugs: Use of ACE inhibitors, b-blockers and central-action drugs, such as methyldopa, was analyzed. Diabetes mellitus: Patients using medicallyprescribed insulin or oral hypoglycemic drugs were considered diabetic. Effectiveness of the hemodialytic treatment was established by calculating the mean index of removal of urea (Kt=V) within the last 6 months. Patients with a mean value greater than 65% were considered to have been adequately dialyzed.
International Index of Erectile Function (IIEF)
In 1993, members of the US National Institute of Health (NIH) recommended the formulation of questionnaires to objectively quantify the degree of ED in such a way as to allow the data to be used in studies of therapeutic efficacy. In 1997, ROSEN and collaborators proposed a questionnaire of 15 items that was both multi-dimensional and self-reporting. 3 This survey assessed the five parameters of male sexual function: erectile function, orgasmic function, sexual drive, level of satisfaction during relations, and overall satisfaction. Questions 1 -5 and question number 15 refer specifically to erectile function and were evaluated in this study. Total scores varied from 0 to 30, and patients can be classified as in Table 1 .
Self-Reporting Questionnaire-20 (SRQ-20)
The SRQ-20 questionnaire, validated in Brazil by Mari and Williams in 1986, was used for the psychoemotional assessment of the patients. This survey was utilized for this study, as it was the only one validated in Portuguese to assess the psychoemotional factors involved with patients suffering from chronic disease. The questionnaire consists of questions requiring simple answers of 'yes' or 'no', with a total score varying between 0 and 20, depending on the number of affirmative responses. When using a cut-off point of 5=6 for men and 7=8 for women, the tool's sensitivity was 89% and 86%, and specificity was 81% and 71%, respectively. In the present study, the same cut-off point used by Mari and Williams was employed; in this manner, those patients with a total score equal to or greater than 8 were classified as having psychogenic morbidity (anxiety or depression). 4 Blood tests requested and results considered normal were the following:
Hemoglobin !11 g=l and hematocrit !33%. Total cholesterol of 121 -200 g=dl and HDL cholesterol of 40 -85 mg=dl. Hormone values as in Table 2 .
The serum titer of hormones was established by means of radioimmunoassay with mono-and polyclonal antibodies, by Kit Coat, using the IRMA count. The rest of the tests were performed using standard laboratory techniques.
Statistical analysis
A descriptive analysis of the socio-demographic, clinical and laboratory data of the patients was carried out. A comparison of the data between (Tables 3 -6 ).
There was no statistically significant difference found between the two groups with respect to duration of hemodialysis, presence of arterial hypertension, or use of antihypertensive drugs ( Table   7 ). The group with ED showed a greater statistical difference in the number of cases of diabetic nephropathy as the CRF etiology (P ¼ 0.05). Another variable which displayed a statistically significant difference between the two groups was smoking, with a greater proportion of smokers in the group possessing ED (P ¼ 0.013). Patients with ED also displayed a greater prevalence of psycho-emotional Chronic renal failure and ED J Cerqueira et al morbidity than did those without the dysfunction (P ¼ 0.005) ( Table 8 ).
An analysis of laboratory data revealed that most of the patients (68%) had normal hematocrit and hemoglobin values. Of the total of 77% of patients using erythropoietin, 90% exhibited normal levels for hematocrit and hemoglobin (Table 9) .
Seventy per cent of the sample studied displayed normal levels of prolactin, and no statistically significant difference in serum levels was found in patients with or without ED, even in those patients with prolactin values greater than 50 ng=ml (data not shown). Also not found were statistical differences in serum levels of testosterone, FSH, LH, and PTH between the two patient groups. Differences were found, however, in the mean values of total cholesterol when comparing between the two groups (P ¼ 0.04) ( Table 9 ).
The final pattern for analysis of logistical regression showed that the variables most strongly associated with the presence of ED were age, psychological morbidity, and dyslipidemia (Table 10 ).
Discussion
The prevalence of ED among patients with CRF was first studied in the 1970s. Initial reports published by ABRAM and collaborators in 1975 showed that the prevalence of ED reached levels of around 80%. 1 In 1981 another study showed a prevalence of 50%. 5 Rodger, Fletcher, Devar and collaborators, while studying 100 chronic renal patients, found ED in 61% of the group. 6 A recent study of 68 patients undergoing peritoneal dialysis continued to show similar results; 63 had severe ED complaints. 7 In the present study, the patients had an average age and duration of dialysis similar to the groups cited above. This work used the IIEF 3 on patients suffering from CRF. Through the use of this index, a prevalence of ED in 57.9% was found in the 119 patients studied, this result being similar to those in the reports mentioned here. This shows that despite the improvements introduced in the treatment of chronic renal patients, prevalence of ED remains high. Again using IIEF, the degree of ED present could be quantified. Evidence of severe ED (28.6%) practically coincided with the sum of slight (14.3%) and moderate (15.1%) degrees of ED.
Age has been a matter for consideration in the origin of ED since publication of the results of the Kinsey Report in 1948. 8 In this study, prevalence of ED in the under-40 population was 1.9% and for men over 60, 25%. Another study showed that the prevalence of ED in apparently healthy individuals up to the age of 55 was 8% and for those over 70, 75%. 9 While evaluating 100 patients with CRF Rodger and collaborators found a strong association between age and the prevalence of ED. The average age of patients with ED was 50, and the average age of those without ED was 38 (P < 0.001). 6 The present study also showed considerable association between age and ED in patients with CRF. While the average age of patients without complaints of ED was approximately 36, the age of patients with complaints of ED averaged 54 y. Sixtysix per cent of patients between 18 and 40 y of age had no ED complaints, as opposed to 6% of those over 60. Another fact observed, was the increase in the number of severe cases of ED as aging took place, from 5.9% in patients up to 40 y to 47% in those over 40. When age was evaluated in association with other variables in the logistical regression analysis, it remained as the factor most strongly associated with ED in this group of patients.
Duration of dialysis proved not to be a determinant factor when associated with the presence of ED Chronic renal failure and ED J Cerqueira et al in the population analyzed; this is supported by other studies. In a group of 68 patients undergoing peritoneal dialysis, studied by Steele and collaborators, association between duration of dialysis and the start of ED also was not found. The mean duration was similar for both groups (24 months vs 27 months). 7 A prospective study, however, has showed that complaints of intensification of sexual dysfunction occurred within the first 3 months of dialytic treatment, with stabilization of symptoms after this adaptation period. 10 In this study, when comparing patients who had been on dialysis for fewer than 3 months with those who had undergone treatment for more than 3 months, no difference in the ED complaints was found.
In the various studies cited in the literature researched, no association between ED and the etiology of CRF was seen, even in those scores that originated from the US, where the main causes of CRF are hypertension and diabetes. 7 In the present study, a major prevalence of ED was found in patients whose etiology of CRF was diabetic nephropathy.
It is reasonable to suppose that diabetic patients with CRF would exhibit an even greater prevalence of sexual dysfunction, as arterial pathology is an important cause of ED in CRF patients. 11 In this study group, 99% of the diabetic patients displayed ED complaints. Only 8% of the patients whose CRF etiology was diabetic nephropathy did not have sexual impotence complaints; on the other hand, 80% of patients with diabetes already had such afflictions before starting dialytic treatment. This data does not permit the affirmation that occurrence of CRF and initiation of dialytic treatment for diabetic patients have led to a worsening of ED symptoms. As for other etiologies, no association whatsoever was found between those pathologies and sexual dysfunction in the patients studied.
The association between smoking and erectile dysfunction has been well documented in the literature. However, during bibliographic research, no work was found that assessed this parameter in patients with ED and CRF.
In this population, 28.5% of the patients were considered cigarette addicts, according to established criteria ( > 10 cigarettes=day). In a singlevariable analysis, prevalence of ED was significantly higher in the group of smokers, when compared to non-smokers (26.9% vs 10%, P ¼ 0.013). However, when logistical regression analysis was performed, it was seen that the age factor acted as a variable of confusion in relation to smoking habits. In other words, the greater the age bracket, the higher the consumption of cigarettes and the greater the period during which the patient had had the addiction.
Since the 1980s, research has been performed to assess the relationship between arterial hypertension and ED. Feldman and collaborators indicated an occurrence of severe ED in 15% of hypertensive patients treated, as opposed to 9% of the general population. 9 In the present study, the prevalence of ED was similar between groups with and without hypertension (27.7% and 22.7%, respectively, P ¼ 0.5). This data allows for the conclusion that there is, apparently, no association between ED and hypertension in patients with CRF.
Wein and van Arsdalen, in a revision survey, listed the principal drugs used by the general population that were associated with ED. Among these are some that are frequently used by patients with renal failure, especially antihypertensive drugs. 12 Only one study was found within the literature that evaluated the association between the existence of ED in chronic renal failure patients and the use of such drugs. The conclusion reached by the authors was that there was no relationship between the two facts. 6 In the present study, ED was of equal distribution among patients using antihypertensive drugs and those that were not (26% vs 21%, P ¼ 0.05). Even those patients using methyldopa did not show significant association with ED.
The physical limitations imposed by dialytic treatment, leading to a reduction of the professional and economic activities of the individual, with a consequent drop in self-esteem, can cause the patient with chronic renal failure to develop symptoms of anxiety and depression. These factors can cause or increase complaints of sexual dysfunction. In the literature, the results are contradictory when broaching factors such as the psychogenic causes of ED in these patients. Assessment of 48 patients with CRF revealed the presence of severe or moderate depression in 43%, but complaints of ED were not significant when the two groups were compared against each other. 5 In another study of 13 patients with renal failure and ED complaints, levels of depression found were similar to those shown by patients who had psychiatric disturbances. It is worth pointing out that three patients with severe ED complaints, high anxiety, and depression showed normal results in a nocturnal tumescence test of the penis, which illustrates the importance of psychogenic factors in these patients. 13 In a study involving 110 men with chronic renal failure and complaints of ED that subjected the patients to a nocturnal penile tumescence test, the authors concluded that 23 (21%) had no organic disturbance to justify their complaints, and the cause of their dysfunction was attributed to psychogenic factors. Another study of 68 patients on a program of continuous peritoneal dialysis showed that the symptoms of depression were greater in patients with severe ED, when compared to those without complaints of dysfunction (P < 0.01). 7 In the present study, of the patients who had psychological morbidity (anxiety and depression) 34.8% had ED, and only 12% did not have this diagnosis. When the regression analysis was This demonstrates that such factors may be involved in the development of or aggravation of ED symptoms in patients with CRF.
Some works have found a relationship between anemia and ED in patients with CRF. Upon evaluation of six patients with ED on a hemodialysis program, a notable increase was perceived in the frequency of sexual relations, from 1.3 to 2.3 relations=month, after the introduction of erythropoietin. Simultaneously, there was a mean increase in hematocrit from 19% to 31.2%. 14 Another study carried out in four chronic renal failure patients reported a subjective improvement of sexual function after 3 months' use of erythropoietin. 15 An increase in blood viscosity was observed during the first 3 months after administration of erythropoietin and may be a possible result of the therapy. In individuals without anemia, blood viscosity remains constant and has no effect on the mechanism of an erection. In the present study, no relationship was found between anemia and ED; this may be explained by the fact that 77% of the patients had been using erythropoietin for more than one year and 90% of these showed normal levels of hematocrit and hemoglobin (Ht > 32% and Hb > 11 g=dl). These patients, after prolonged use of erythropoietin, probably behaved like normal patients; thus, blood viscosity does not appear to play an important role in penile blood pressure.
Hyperprolactinemia is an alteration found in 25 -55% of patients with CRF. The mechanism by which high levels of prolactin could cause ED symptoms in patients with CRF has not yet been defined. Alterations in libido could contribute to ED-related complaints in this group of patients. 16 Some authors indicate that administration of erythropoietin could play a part in the correction of prolactin levels, resulting in improvement in the complaints of erectile dysfunction. In a study with seven male patients, prolactin declined significantly after commencement of erythropoietin treatment (from 39.5 ng=ml to 10.3 ng=ml). Through use of the questionnaire, Schaefer and collaborators found a subjective improvement of sexual function in four of the seven patients. 17 Rodger and Fletcher, analyzing 100 patients in hemodialysis programs, showed that the mean serum prolactin values were similar between patients with and without erectile dysfunction (822 mU=ml vs 645 mU=ml). 6 The present results show that 70% of the patients studied had normal prolactin levels. Of these, 38% had ED complaints, in contrast with the 61% who did not (P ¼ 0.418). Furthermore, in those patients with levels of prolactin considered very high ( > 50 mg=ml), there was no significant association between ED and hyperprolactinemia. Thus, from these results and those of other works cited here, the improvement in ED complaints which occurs after initiation of treatment with erythropoietin, shown in some studies, appears to be due more to the initial effect of increase in blood viscosity than to the normalization in prolactin levels. It seems that administration of erythropoietin improves serum prolactin levels by mechanisms that as of yet remain unknown.
The cause of testicular histological alterations seen in patients with CRF is not well defined. It is believed that substances used in the dialysis capillaries are responsible for these alterations. 16 It is known that the presence of hypergonadotrophic hypogonadism in patients without CRF is the cause of ED in such patients and that normalization of serum levels of testosterone through intramuscular applications of the hormone leads to restoration of normal sexual function. 18 These findings led to an attempt to associate low levels of testosterone in CRF patients with ED. In an analysis of 100 patients on hemodialysis, with an average age of 50 and onset of ED complaints 2 y prior to the study, only 12 showed levels of testosterone below normal (8.5 nmol=l -27.5 mol=l); only one patient responded positively to the attempt to correct ED through hormonal replacement. 6 Paolo and Capotondo followed during 18 months a group of 13 patients who had an average age of 41 y and complaints of ED for about 6 months; they found that testosterone levels suffered negligible variations, from 3 ng=ml to 2.8 ng=ml. Simultaneously, the authors noted that ED complaints began mainly within the first 3 months after the start of treatment, thus demonstrating the lack of association between endocrine alterations and ED in patients with CRF. 10 Seventy-seven per cent of the patients in this study showed levels of testosterone considered normal (13 -40 pg=ml) . The mean serum testosterone in patients with ED was 28.3 pg=ml and in patients without ED, 32.3 pg=ml (P ¼ 0.79). This shows the lack of association between levels of serum testosterone and complaints of ED in patients with CRF, confirming the findings already published in the literature.
The part played by dyslipidemia in the genesis of ED in various groups of patients has been well established in the scientific literature. One study in 1994 showed that the risk of moderate impotence increased from 6.7 to 25% in patients aged 40 -55 y, when the levels of HDL cholesterol dropped from 90 mg=ml to 30 mg=ml. This same study showed that patients aged 56 -70 with the same reduction in levels of HDL-cholesterol experienced an increase in severe ED, from 0 to 16%. Total cholesterol values were not associated with the prevalence of ED. 9 Despite lipid metabolism disturbance (which generates hypertriglyceridemia and reduction in levels of high-density lipoproteins) having been found in patients with chronic renal failure, Chronic renal failure and ED J Cerqueira et al research that tried to associate these alterations with the presence of ED in such patients was not encountered when examining the bibliography. Evaluation of the levels of cholesterol in the present study revealed that patients with ED exhibited total cholesterol levels significantly greater than those of patients without ED (157.6 mg=ml AE 38.6 mg=ml vs 143.7 mg=ml AE 33.2 mg=ml, P < 0.04). Multivariable regression analysis showed that even when levels of cholesterol are associated with other confusing variables such as age, smoking, and hypertension, rates of cholesterol remained an independent factor strongly associated with the presence of ED in patients with CRF.
Conclusions
This study showed that the prevalence of ED in patients with CRF is high (57.9%). The age factor, as in other groups studied in the literature, was shown to be the main variable associated in patients with CRF. No relationship between ED and other sociodemographic variables was found. Alterations in the levels of high-density lipoprotein (HDL) and factors such as anxiety and depressive complaints, appear to play an important part in the origin of ED in patients with CRF.
